1,080
Participants
Start Date
November 30, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
August 31, 2031
LY4170156
Administered IV
Paclitaxel
Administered IV
Topotecan
Administered IV
Gemcitabine
Administered IV
Pegylated liposomal doxorubicin
Administered IV
MIRV
Administered IV
Bevacizumab
Administered IV
Carboplatin
Administered IV
Laura and Isaac Perlmutter Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
Hospital Angeles, Tijuana
Scientia Investigacion Clinica S.C., Chihuahua City
University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Florida Cancer Specialist- East, West Palm Beach
Florida Cancer Specialist- South, Fort Myers
Norton Women's and Children's Hospital, Louisville
Oncology Hematology Care Inc, Cincinnati
Centro Oncologico Estatal ISSEMyM ( COEI ), Toluca
Illinois Cancer Specialists, Arlington Heights
Northwestern Memorial Hospital, Chicago
Trials 365, Shreveport
Unidad Médica Onco-hematológica, Puebla City
PanAmerican Clinical Research - Querétaro - Avenida Antea, Querétaro
US Oncology, The Woodlands
USO-Texas Oncology-Central/South Texas, Austin
HonorHealth, Phoenix
Sansum Clinic, Solvang
Centro de Atención E Investigación Clínica En Oncología, Mérida
USO - Oncology Associates of Oregon, P. C., Eugene
Beijing Cancer hospital, Beijing
The First Hospital of Jilin University, Changchun
Zhejiang Cancer Hospital, Hangzhou
Xiangya Hospital Central South University, Changsha
The First People's Hospital of Changde City, Changde
Wuhan Union Hospital, Wuhan
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Cancer Hospital of Shantou University Medical College, Shantou
Guangxi Medical University Affiliated Tumor Hospital, Nanning
University of Massachusetts Chan Medical School, Worcester
USO - Texas Oncology Gulf Coast, Webster
Centre intégré universitaire de santé et de services sociaux de l'Estrie Centre Hospitalier Universitaire -T, Sherbrooke
Princess Margaret Cancer Centre, Toronto
Saitama Medical University International Medical Center, Hidaka
CENEIT Oncologicos, Mexico City
Health Pharma Professional Research S.A. de C.V:, Mexico City
COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City
GOG Foundation
NETWORK
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Asia-Pacific Gynecologic Oncology Trials Group (APGOT)
UNKNOWN
Eli Lilly and Company
INDUSTRY